Evidence map›Paper›PMID 35942995›Full record

ArticleArchives of Iranian medicine2022

Clinical Features and Prognosis in ANCA Associated Vasculitis Patients with Acute Kidney Injury.

Yue Chen, Yuqiu Lu, Ying Zhou, Chen Yu

Open access · hybridAbstract read
In one paragraph

Article in Archives of Iranian medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Yue ChenDepartment of Nephrology, Tongji Hospital, Tongji University School of Medicine, Shanghai, China.ORCID 0000-0002-6801-528X
Yuqiu LuDepartment of Nephrology, Tongji Hospital, Tongji University School of Medicine, Shanghai, China.
Ying ZhouDepartment of Nephrology, Tongji Hospital, Tongji University School of Medicine, Shanghai, China.
Chen YuDepartment of Nephrology, Tongji Hospital, Tongji University School of Medicine, Shanghai, China.ORCID 0000-0001-7169-276X
Tongji University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRenal involvement in patients with anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV) often presents as acute kidney injury (AKI), which is closely related to the prognosis of critically ill patients. Nevertheless, there are few researches on the subgroup of AVV patients with AKI. The study aimed to explore clinical features and prognosis in AAV patients with AKI.

methodsA retrospective analysis of AAV patients was conducted. The enrolled patients were grouped according to whether AKI on admission occurred or not. Demographic, clinical data and follow-up records were gathered from medical histories. Survival rates of AAV patients with AKI and risk factors of all AAV patients were studied.

results(1) In the AKI group, the levels of hemoglobin, evaluated glomerular filtration rate (eGFR), serum albumin and complement 3 were significantly lower (

conclusionAAV patients with AKI have more severe kidney damage, higher disease activity and worse prognosis. More attention should be paid to AAV patients with AKI for both remission induction and infection prevention.

Indexed as

Acute Kidney InjuryAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisAntibodies, Antineutrophil CytoplasmicHumansPrognosisRetrospective StudiesAntibodies, Antineutrophil CytoplasmicAcute kidney injuryAnti-neutrophil cytoplasmic antibody associated vasculitisPrognosisRisk factors

Identifiers

PMID35942995
PMCPMC11897876
OpenAlexW4293108223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.